BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32061921)

  • 1. ARID3A and ARID3B induce stem promoting pathways in ovarian cancer cells.
    Dausinas P; Pulakanti K; Rao S; Cole JM; Dahl R; Cowden Dahl KD
    Gene; 2020 May; 738():144458. PubMed ID: 32061921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct and overlapping roles of ARID3A and ARID3B in regulating E2F‑dependent transcription via direct binding to E2F target genes.
    Saadat KASM; Lestari W; Pratama E; Ma T; Iseki S; Tatsumi M; Ikeda MA
    Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARID3A and ARID3B exert direct regulatory control over the long non-coding RNAs (lncRNAs) MALAT1 and NORAD within the context of non-small cell lung cancer (NSCLC).
    Nasuh S; Balci SO; Bozgeyik I; Ikeda MA; Tekayev M; Saadat KASM
    Pathol Res Pract; 2023 Dec; 252():154948. PubMed ID: 37977034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of ARID3B in the expression of pro-apoptotic p53-target genes and apoptosis.
    Pratama E; Tian X; Lestari W; Iseki S; Ichwan SJ; Ikeda MA
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):248-54. PubMed ID: 26519881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arid3b Is Critical for B Lymphocyte Development.
    Kurkewich JL; Klopfenstein N; Hallas WM; Wood C; Sattler RA; Das C; Tucker H; Dahl R; Cowden Dahl KD
    PLoS One; 2016; 11(8):e0161468. PubMed ID: 27537840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARID3B Directly Regulates Ovarian Cancer Promoting Genes.
    Bobbs A; Gellerman K; Hallas WM; Joseph S; Yang C; Kurkewich J; Cowden Dahl KD
    PLoS One; 2015; 10(6):e0131961. PubMed ID: 26121572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARID3B increases ovarian tumor burden and is associated with a cancer stem cell gene signature.
    Roy L; Samyesudhas SJ; Carrasco M; Li J; Joseph S; Dahl R; Cowden Dahl KD
    Oncotarget; 2014 Sep; 5(18):8355-66. PubMed ID: 25327563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. let-7 Modulates Chromatin Configuration and Target Gene Repression through Regulation of the ARID3B Complex.
    Liao TT; Hsu WH; Ho CH; Hwang WL; Lan HY; Lo T; Chang CC; Tai SK; Yang MH
    Cell Rep; 2016 Jan; 14(3):520-533. PubMed ID: 26776511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harnessing stemness and PD-L1 expression by AT-rich interaction domain-containing protein 3B in colorectal cancer.
    Liao TT; Lin CC; Jiang JK; Yang SH; Teng HW; Yang MH
    Theranostics; 2020; 10(14):6095-6112. PubMed ID: 32483441
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential expression of ARID3B in normal adult tissue and carcinomas.
    Samyesudhas SJ; Roy L; Cowden Dahl KD
    Gene; 2014 Jun; 543(1):174-80. PubMed ID: 24704276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LIN28-
    Ali A; Anthony RV; Bouma GJ; Winger QA
    FASEB J; 2019 Nov; 33(11):12348-12363. PubMed ID: 31415216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARID3B induces tumor necrosis factor alpha mediated apoptosis while a novel ARID3B splice form does not induce cell death.
    Joseph S; Deneke VE; Cowden Dahl KD
    PLoS One; 2012; 7(7):e42159. PubMed ID: 22860069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a new ARID family transcription factor (Brightlike/ARID3C) that co-activates Bright/ARID3A-mediated immunoglobulin gene transcription.
    Tidwell JA; Schmidt C; Heaton P; Wilson V; Tucker PW
    Mol Immunol; 2011 Oct; 49(1-2):260-72. PubMed ID: 21955986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARID3a from the ARID family: structure, role in autoimmune diseases and drug discovery.
    Guo CC; Xu HE; Ma X
    Acta Pharmacol Sin; 2023 Nov; 44(11):2139-2150. PubMed ID: 37488425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REKLES is an ARID3-restricted multifunctional domain.
    Kim D; Probst L; Das C; Tucker PW
    J Biol Chem; 2007 May; 282(21):15768-77. PubMed ID: 17400556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARID3A promotes the development of colorectal cancer by upregulating AURKA.
    Tang J; Yang L; Li Y; Ning X; Chaulagain A; Wang T; Wang D
    Carcinogenesis; 2021 Apr; 42(4):578-586. PubMed ID: 33165575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YAP/TEAD co-activator regulated pluripotency and chemoresistance in ovarian cancer initiated cells.
    Xia Y; Zhang YL; Yu C; Chang T; Fan HY
    PLoS One; 2014; 9(11):e109575. PubMed ID: 25369529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ARID family transcription factor bright is required for both hematopoietic stem cell and B lineage development.
    Webb CF; Bryant J; Popowski M; Allred L; Kim D; Harriss J; Schmidt C; Miner CA; Rose K; Cheng HL; Griffin C; Tucker PW
    Mol Cell Biol; 2011 Mar; 31(5):1041-53. PubMed ID: 21199920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic ARID3A facilitates liver cancer malignancy by cooperating with CEP131 to regulate an embryonic stem cell-like gene signature.
    Shen M; Li S; Zhao Y; Liu Y; Liu Z; Huan L; Qiao Y; Wang L; Han L; Chen Z; He X
    Cell Death Dis; 2022 Aug; 13(8):732. PubMed ID: 36008383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State.
    Chien CS; Wang ML; Chu PY; Chang YL; Liu WH; Yu CC; Lan YT; Huang PI; Lee YY; Chen YW; Lo WL; Chiou SH
    Cancer Res; 2015 Jun; 75(12):2553-65. PubMed ID: 25858147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.